Agarwal, A., Meckenzie, R. J., Pippa, R., Eide, C. A., Oddo, J., Tyner, J. W., … Druker, B. J. (2013). OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias. In Blood (Vol. 122, pp. 2511–2511). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.2511.2511

Agarwal, Anupriya, Ryan J. Meckenzie, Raffaella Pippa, Christopher A. Eide, Jessica Oddo, Jeffrey W. Tyner, Rosalie Sears, et al. “OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias.” In Blood, 122:2511–2511. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.2511.2511.

Agarwal A, Meckenzie RJ, Pippa R, Eide CA, Oddo J, Tyner JW, et al. OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias. In: Blood. American Society of Hematology; 2013. p. 2511–2511.

Agarwal, Anupriya, et al. “OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 2511–2511. Crossref, doi:10.1182/blood.v122.21.2511.2511.

Agarwal A, Meckenzie RJ, Pippa R, Eide CA, Oddo J, Tyner JW, Sears R, Vitek MP, Odero MD, Christensen DJ, Druker BJ. OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias. Blood. American Society of Hematology; 2013. p. 2511–2511.